Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease (Q36362707)

13 August 2017

1 reference

title

Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease (English)

1 reference

13 August 2017

0 references

0 references

coronary artery disease

1 reference

Janet H Southerland

1

1 reference

13 August 2017

George W Taylor

2

1 reference

13 August 2017

Kevin Moss

3

1 reference

13 August 2017

James D Beck

4

1 reference

13 August 2017

Steven Offenbacher

5

1 reference

13 August 2017

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

40

1 reference

13 August 2017

130-143

1 reference

Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Oral disease, cardiovascular disease and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The role of nuclear factor-kappa B in cytokine gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Lilly Lecture 1993. Glycation and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Periodontal pathogens in atheromatous plaques. A controlled clinical and laboratory trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

RAGE (receptor for advanced glycation end products): a central player in the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The AGE of the matrix: chemistry, consequence and cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The metabolic syndrome and inflammation: association or causation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Role of cytokines in inducing hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The hematopoietic activities of interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Cytokines stimulate lipolysis and decrease lipoprotein lipase activity in cultured fat cells by a prostaglandin independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Periodontal conditions in insulin-dependent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Oxidized low-density lipoproteins may induce expression of monocyte chemotactic protein-3 in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The Maillard or browning reaction in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Lipoprotein glycation and its metabolic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Does leptin resistance contribute to infections in patients with diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Rel/NF-kappa B and I kappa B proteins: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Microbial/host interactions: mechanisms involved in host responses to microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

CHD: a major burden in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Input and Output Characteristics of Collision Avoidance Behavior in the Frog <i>Rana catesbeiana</i>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Advanced glycoxidation. A new risk factor for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Modulation of insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

CD14 is a pattern recognition receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Periodontal infections and atherosclerosis: mere associations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Porphyromonas gingivalis induces murine macrophage foam cell formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

21 January 2018

The acute phase response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Type 2 diabetes: epidemiologic trends, evolving pathogenetic [corrected] concepts, and recent changes in therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Microbial complexes in subgingival plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Metabolic syndrome and other factors associated with increased risk of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Protein glycation: a firm link to endothelial cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

MyD88: an adapter that recruits IRAK to the IL-1 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

21 January 2018

Epidemiology of diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Periodontal disease as we approach the year 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0757.2005.00138.X

10.1111/J.1600-0757.2005.00138.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference